US 11,840,518 B2
Use of bromophenol-pyrazoline compounds for the treatment of feline coronavirus diseases
Dayong Shi, Weihai (CN); Xiangqian Li, Weihai (CN); Xin Wang, Weihai (CN); and Feng Xu, Weihai (CN)
Assigned to Shandong Linghai Biotechnology Co., Ltd., Weihai (CN)
Filed by Shandong Linghai Biotechnology Co., Ltd., Weihai (CN)
Filed on Jul. 21, 2022, as Appl. No. 17/869,819.
Claims priority of application No. 202111190625.5 (CN), filed on Oct. 13, 2021.
Prior Publication US 2022/0363644 A1, Nov. 17, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 231/06 (2006.01); A61P 31/14 (2006.01)
CPC C07D 231/06 (2013.01) [A61P 31/14 (2018.01)] 9 Claims
 
1. A method of treating a feline coronavirus disease in a subject, comprising:
administering to the subject in need thereof an effective amount of a bromophenol-pyrazoline compound of following formula:

OG Complex Work Unit Chemistry